Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation
Key facts
- Where
- London és Ottawa, KanadaSee the 2 sites
Where in Kanada
- London Health Sciences NetworkLondon, KanadaTaking people
- University of Ottawa Heart InsititueOttawa, KanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ottawa Heart Institute Research Corporation
- Trial code
- NCT03397602
- Record updated
- 2026. március 11.
- Original description
The main purpose of this project is to evaluate the effects of high-intensity interval training (HIIT) compared to moderate-intensity continuous exercise training (MICE) and standard care on exercise capacity and quality of life in patients with persistent or permanent atrial fibrillation. Positive findings are vitally important for these patients, given the condition's substantial morbidity, mortality and high economic costs.Read full original descriptionShow less
Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation - a Multi-centre Randomized Controlled Trial
The main purpose of this project is to evaluate the effects of high-intensity interval training (HIIT) compared to moderate-intensity continuous exercise training (MICE) and standard care on exercise capacity and quality of life in patients with persistent or permanent atrial fibrillation. Positive findings are vitally important for these patients, given the condition's substantial morbidity, mortality and high economic costs.
Inclusion: persistent or permanent atrial fibrillation; rate controlled with a resting ventricular rate of equal to or less than 100 bpm; able to perform a symptom-limited exercise test; at least 40 years of age (i.e. participants must be 40 years or older).
Exclusion: unstable angina; currently participating in routine exercise training (more than two times per week); diagnosed severe mitral or aortic stenosis; diagnosed hypertrophic obstructive cardiomyopathy with significant obstruction; pregnant, lactating or planning to become pregnant during the study period; unable to provide written, informed consent, or; unwilling or unable to return for follow up at week 12.